150+ Trials And 30th Oncology Trial On SYMYOO’s 9th Anniversary
Conducted more than 150 clinical studies, including 30 oncology trials over 9 years since its foundation in 2009. Symyoo had been coordinating and collaborating with various
symyoo
Introducing SYMYOO EDC, SYNeRA™
Launched Symyoo EDC system, SYNeRA™ for clinical research data collection and management. Symyoo SMART TRIALS research center continues to develop and expand SYNeRA™ functionalities into a web-based Comprehensive Clinical Trial Management System.
Partnership With KU Anam Hospital
Began research collaboration with Global Clinical Trial Center of Anam Hospital, Korea University Medical Center
Korea CRO Association Member
Qualified for full membership in Korea Clinical Trial CRO Association.
SMART TRIALS Research Center
Established SMART TRIALS center to research and facilitate new IT technologies for tomorrow’s medicines. Symyoo reorganized data management and biostatistics team to offer broader data management services.
Partnership With Inje Clinical Trial Center
Partnership contract with Clinical Trial Center of Baek University Hospital, Inje University
First Global Phase III Trial As Coordinating Center
Symyoo was designated as the Korea coordinating center to run a multinational phase III clinical trial, which was the first NIH/NINDS study (ATACH 2: Antihypertensive Treatment of Acute Cerebral Hemorrhage II) operated in South Korea. The sponsor audit was also conducted to evaluate trial conduct and compliance with the protocol and SOPs without finding any … First Global Phase III Trial As Coordinating Center
First Phase III Pivotal Trial
Symyoo expanded its business into a full scope CRO and began to operate a first phase III trial for premature ejaculation study.
SYMYOO Founded
Dongjin Yoo, CEO & MD, founded a CRO to help K-Bio industry’s clinical development after his successful journey as a CEO and medical director of many global pharmaceuticals and bio startups.